Pfizer-BioNTech files for U.S. approval of COVID-19 vaccine
Pfizer-BioNTech files for U.S. approval of COVID-19 vaccine
May 07, 2021
Pfizer and German partner BioNTech have filed for a full U.S. approval for their COVID-19 vaccine, which is now authorized only for emergency use, the drugmakers said on Friday.
Post A Comment:
0 comments:
Leave a comment. Thanks!